HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donor-derived disorders of hemostasis and thrombosis in liver transplantation: Considerations for deceased donor liver selection.

Abstract
OLT is known to be associated with a precarious perioperative hemostatic state due to dysregulation of procoagulant and anticoagulant factors, endothelial injury, and inflammation. Transmission of inherited bleeding and clotting disorders from the liver donor to the recipient may further complicate hemostasis during and after transplantation. As a result, consideration of congenital coagulation disorders in the liver donor is a practical concern for donor selection. However, there is no clear consensus regarding the selection of donors with known or suspected thrombophilia or bleeding disorders. While multiple case reports and retrospective studies, subject to reporting bias, describe donor-derived thrombophilic and bleeding disorders, there are no large-scale studies in the adult liver transplant literature that examine the frequency of transmission, utility of donor screening, or clinical impact of donor hemostatic disorders. Based on the reported literature, we summarize our approach for donor selection with an aim to balance improved organ utility and optimal post-transplant outcomes.
AuthorsSrilakshmi Atthota, Anne MacDonald, James F Markmann, David Kuter, Nahel Elias, Heidi Yeh, Walter H Dzik, Leigh Anne Dageforde
JournalLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (Liver Transpl) Vol. 29 Issue 10 Pg. 1109-1117 (10 01 2023) ISSN: 1527-6473 [Electronic] United States
PMID37486918 (Publication Type: Journal Article)
CopyrightCopyright © 2023 American Association for the Study of Liver Diseases.
Topics
  • Adult
  • Humans
  • Liver Transplantation (adverse effects)
  • Donor Selection
  • Retrospective Studies
  • Living Donors
  • Liver (surgery)
  • Thrombosis (etiology)
  • Hemostasis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: